Fluvoxamine Long COVID Fatigue: McMaster Study | AcademicJobs
McMaster University researchers lead trial showing fluvoxamine reduces long COVID fatigue, highlighting Canada's higher ed role in global health innovation.
No reviews yet. Be the first to rate Gilmar!
Dr. Gilmar Reis is Associate Professor (Part-Time) in Health Research Methods, Evidence, and Impact at McMaster University. He received his MD from Universidade Federal de Minas Gerais in Belo Horizonte, Brazil, in 1989, followed by a cardiology fellowship and board certification at Hospital Vera Cruz in Belo Horizonte in 1992. He completed a research fellowship and master’s degree at the University of Michigan in Ann Arbor in 1993. His PhD, focused on rheumatic diseases, was awarded by the Heart Institute at the University of São Paulo Medical School in 2001. Since 2003, he has served as Associate Professor of Medicine at Pontifical Catholic University of Minas Gerais. He is a Fellow of the American College of Cardiology and the European Society of Cardiology since 2011. Dr. Reis has directed the Clinical Research Unit at Cardresearch in Brazil and has led numerous multicentric clinical trials in cardiology and intensive care medicine. During the COVID-19 pandemic, he designed and led the adaptive TOGETHER Trial, which evaluated interventional therapies for early COVID-19 and produced multiple publications while contributing to public health efforts in partnership with Brazilian authorities and McMaster researchers. The trial was nominated for the David Sackett Award as Best Trial of the Year 2021 by the Society for Clinical Trials.
His work emphasizes clinical and translational cardiovascular sciences, global health, and population health interventions. Through extensive collaborations, Dr. Reis has helped build research capacity across more than 40 Brazilian cities and advanced evidence-based approaches to infectious disease management.
McMaster University researchers lead trial showing fluvoxamine reduces long COVID fatigue, highlighting Canada's higher ed role in global health innovation.